Optimum management of elderly patients with calcified aortic stenosis

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 4, 2008, Pages 491-501

  Kappetein, A Pieter ^a   van Geldorp, Martijn ^a   Takkenberg, Johanna J M ^a   Bogers, Ad J J C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aortic valve; Aortic valve surgery; Elderly patients; Outcome valve surgery; Pathogenesis aortic stenosis; Percutaneous valve; Trans apical valve replacement

Indexed keywords

ATORVASTATIN; BRAIN NATRIURETIC PEPTIDE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITROPRUSSIDE SODIUM;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; AORTIC VALVE REPAIR; ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; ELDERLY CARE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART VALVE BIOPROSTHESIS; HEART VALVE REPLACEMENT; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LIFE EXPECTANCY; LUNG CONGESTION; MORBIDITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATHOGENESIS; POSTOPERATIVE HEMORRHAGE; QUALITY OF LIFE; REOPERATION; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; STRESS ECHOCARDIOGRAPHY; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL TIME; SYNCOPE; TRANSLUMINAL VALVULOPLASTY; AGED; AORTA VALVE; AORTA VALVE STENOSIS; CALCINOSIS; METHODOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; TIME;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; DISEASE PROGRESSION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 43049175101     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.4.491     Document Type: Review

References (68)

1. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J. Am. Coll. Cardiol. 21(5), 1220-1225 (1993).
2. Stewart MDFBF, Siscovick MDMPHD, Lind MSBK et al. Clinical Factors Associated With Calcific Aortic Valve Disease. J. Am. Coll. Cardiol. 29(3), 630-634 (1997).
3. Kaden JJ, Dempfle C-E, Grobholz R et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc. Pathol. 14(2), 80-87 (2005).
4. O'Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler. Thromb. Vasc. Biol. 26(8), 1721 (2006).
5. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly. N. Engl. J. Med. 341(3), 142-147 (1999).
6. Bouma BJ, van den Brink RB, Der Meulen JH et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 82(2), 143-148 (1999).
7. Otto CM. Timing of aortic valve surgery. Heart 84(2), 211-218 (2000).
8. Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J. Am. Coll. Cardiol. 2141-2151 (2006).
9. Eslami M, Rahimtoola SH. Decision to perform concomitant aortic valve replacement in patients undergoing coronary bypass surgery: current thinking. ACC Curr. J. Rev. 10(6), 84-87 (2001).
10. Baumgartner H. Hemodynamic assessment of aortic stenosis: are there still lessons to learn? J. Am. Coll. Cardiol. 47(1), 138-140 (2006).
11. Lange RA, Hillis LD. Dobutamine stress echocardiography in patients with low-gradient aortic stenosis. Circulation 113(14), 1718-1720 (2006).
12. Monin JI, Quéré JP, Monchi M et al. Low-gradient aortic stenosis. Circulation 108, 319 (2003).
13. Bamgartner H. Is there a role for multislice computed tomography in aortic stenosis? Eur. Heart J. 27(24), 2923-2924 (2006).
14. Bergler-Klein J, Mundigler G, Pibarot P et al. B-Type Natriuretic Peptide in Low-Flow, Law-Gradient Aortic Stenosis: Relationship to Hemodynamics and clinical outcome: results from the multicenter truly or pseudosevere aortic stenosis (TOPAS) study. Circulation 115(22), 2848-2855 (2007).
15. Bergler-Klein J, Klaar U, Heger M et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 109(19), 2302-2308 (2004).
16. Gerber IL, Stewart RAH, Legget ME et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 107(14), 1884-1890 (2003).
17. Rosenhek R. Rader F, Loho N et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 110(10), 1291-1295 (2004).
18. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-a reductase inhibitor treatment, and progression of aortic stenosis in the community. Am. Coll. Cardio Found. 1723-1730 (2002).
19. Chua D, Kalb K. Statins and progression of calcified aortic stenosis. Ann. Pharmacother. 40(12), 2195 (2006).
20. Moura LM, Ramos SF, Zamorano JL et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J. Am. Coll. Cardiol. 49(5), 554-561 (2007).
21. Cowell SJ, Newby DE, Prescott RJ et al. A Randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med. 352(23), 2389-2397 (2005).
22. Newby DE, Cowell SJ, Boon NA. Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both? Heart 92(6), 729-734 (2006).
23. Helske S, Lindstedt KA, Laine M et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J. Am. Coll. Cardiol. 44(9), 1859-1866 (2004).
24. Nilsson J, Algotsson L, Hoglund P, Luhrs C, Brandt J. Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur. Heart J. 27(7), 867 (2006).
25. Kolh P. Importance of risk stratification models in cardiac surgery. Eur. Heart J. 27(7), 768-769 (2006).
26. Hannan EL, Wu C, Bennett EV et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann. Thoracic. Surg. 83(3), 921-929 (2007).
27. Takkenberg JJ, Puvimanasinghe JP, Grunkemeier GL. Simulation models to predict outcome after aortic valve replacement. Ann. Thorar. Surg. 75(5), 1372-1376 (2003).
28. Iung B, Cachier A, Baron G et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur. Heart J. 26(24), 2714 (2005).
29. Pellikka PA, Sarano ME, Nishimura RA et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111(24), 3290-3295 (2005).
30. Bach DS, Radeva JI, Birnbaum HG, Fournier AA, Tuttle EG. Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind? J. Heart Valve Dis. 16(4), 362-369 (2007).
31. Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114(5), e84-e231 (2006).
32. Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 28(2), 230-268 (2007).
33. Lieberman EB, Bashore TM, Hermiller JB et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J. Am. Coll. Cardiol. 26(6), 1522-1528 (1995).
34. Otto CM, Mickel MC, Kennedy JW et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 89(2), 642-650 (1994).
35. Hara H, Pedersen WR, Ladich E et al. Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance? Circulation 115(12), e334-e338 (2007).
36. Frank S, Johnson A, Ross J Jr. Natural history of valvular aortic stenosis. Br. Heart J. 35(1), 41-46 (1973).
37. Lund O, Bland M. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. J. Thoracic. Card. Surg. 132(1), 20-26 (2006).
38. Aupart MR, Mirza A, Meurisse YA, Sirinelli AL, Neville PH, Marchand MA. Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients. J. Heart Valve Dis. 15(6), 768-775 (2006).
39. Kappetein AP, Puvimanasinghe JPA, Takkenberg JJM, Steyerberg EW, Bogers AJJC. Predicted patient outcome after aortic valve replacement with medtronic stentless freestyle bioprostheses. J. Heart Valve Dis. 16(4), 423-429 (2007).
40. Kappetein AR Takkenberg JJM, Puvimanasinghe JPA, Jamieson WRE, Eijkemans M, Bogers AJJC. Does the type of biological valve affect patient outcome? Interact. Cardiovasc. Thorac. Surg. 5(4), 398-402 (2006).
41. Sundt TM, Bailey MS, Moon MR et al. Quality of life after aortic valve replacement at the age of >80 years. Circulation 102(90003), III-70-III-74 (2000).
42. Melby SJ, Zierer A, Kaiser SP et al. Aortic valve replacement in octogenarians: risk factors for early and late mortality. Ann. Thorac. Surg. 83(5), 1651 (2007).
43. Florath I, Rosendahl UP, Mortasawi A et al. Current determinants of operative mortality in 1400 patients requiring aortic valve replacement. Ann. Thorac. Surg. 76(1), 75-83 (2003).
44. Kolb P, Kerzmann A, Honore C, Comte L, Limet R. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur. J. Cardiothorac. Surg. 31(4), 600 (2007).
45. Katz NM, Hannan RL, Hopkins RA, Wallace RB. Cardiac operations in patients aged 70 years and over: mortality, length of stay, and hospital charge. Ann. Thorac. Surg. 60(1), 96-100 (1995).
46. Srinivasan AK, Oo AY, Grayson AD et al. Mid-term survival after cardiac surgery in elderly patients: analysis of predictors for increased mortality. Interact. Cardiovasc. Thorac. Surg. 3(2), 289-293 (2004).
47. Thulin J. Quality of life in the very elderly after cardiac surgery: a comparison of sf-36 between long-term survivors and an age-matched population. Gerontology 50, 407-410 (2004).
48. Kolh P, Kerzmann A, Lahaye L, Gerard P, Limet R. Cardiac surgery in octogenarians. Peri-operative outcome and long-term results. Eur. Heart J. 22(14), 1235-1243 (2001).
49. Sedrakyan A, Vaccarino V, Paltiel AD et al. Age does not limit quality of life improvement in cardiac valve surgery. J. Am. Coll. Cardiol. 42(7), 1208-1214 (2003).
50. Cerillo AG, Al Kodami A. Aortic valve surgery in the elderly patient: a retrospective review. Interact. Cardiovasc. Thorac. Surg. 6(3), 308 (2007).
51. Langanay T, De Latour B, Ligier K et al. Surgery for aortic stenosis in octogenarians: influence of coronary disease and other comorbidities on hospital mortality. J. Heart Valve Dis. 13 (4), 545-552 (2004).
52. Richardson JV, Kouchoukas NT, Wright JO, Karp RB. Combined aortic valve replacement and myocardial revascularization: results in 220 patients. Circulation, 59(1), 75-81 (1979).
53. Smith WT, Ferguson TB, Ryan T, Landolfo CK, Peterson ED. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J. Am. Coll. Cardiol. 44(6), 1241-1247 (2004).
54. Rahimtoola SH. Should patients with asymptomatic mild or moderate aortic stenosis undergoing coronary artery bypass surgery also have valve replacement for their aortic stenosis? Heart 85(3), 337-341 (2001).
55. Moazami N, Diodato MD, Moon MR et al. Does functional mitral regurgitation improve with isolated aortic valve replacement? J. Cardiac Surg. 19(5), 444-448 (2004).
56. Ruel M, Kapila V, Price J, Kulik A, Burwash IG, Mesana TG. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation 114(1 Suppl.) (2006).
57. Byrne JG, Karavas AN, Filsoufi F et al. Aortic valve surgery after previous coronary artery bypass grafting with functioning internal mammary artery grafts. Ann. Thorac. Surg. 73(3), 779-784 (2002).
58. Shanmugam G. Aortic valve replacement following previous coronary surgery. Eur. J. Cardiothorac. Surg. 28(5), 731-735 (2005).
59. Potter DD, Sundt TM, Zehr KJ et al. Operative risk of reoperative aortic valve replacement. J. Thoracic. Card. Surg. 129(1), 94-103 (2005).
60. Eitz T, Fritzsche D, Kleikamp G, Zittermann A, Horstkotte D, Korfer R. Reoperation of the Aortic Valve in Octogenarians. Ann. Thoracic. Surg. 82(4), 1385 (2006).
61. Ghosh P, Holthouse D, Carroll I, Larbalestier R, Edwards M. Cardiac reoperations in octogenerians. Eur. J. Cardiothorac. Surg. 15(6), 809 (1999).
62. Cohn LH, Narayanasamy N. Aortic valve replacement in elderly patients: what are the limits? Curr. Opin. Card. 22(2), 92-95 (2007).
63. Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 106(24), 3006-3008 (2002).
64. Lichtenstein SV, Cheung A, Ye J et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114(6), 591 (2006).
65. Grube E, Labofde JC, Gerckens U et al. Percutaneous implantation of the corevalve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg First-in-Man Study. Circulation 114(15), 1616 (2006).
66. De Jaegere P, Van Dijk LC, Laborde JC et al. True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar® XL and the TandemHeart®. EuroIntervention 2(4), 500-505 (2007).
67. Walther T, Falk V, Borger MA et al. Minimally invasive transapical beating heart aortic valve implantation - proof of concept. Eur. J. Cardiothorac. Surg. 31(1), 9-15 (2007).
68. Thomas Walther MD, Volkmar Falk MD, Todd Dewey MD et al. Valve-in-a-valve concept for transcatheter minimally invasive repeat xenograft implantation. J. Am. Coll. Cardiol. 50(1), 56-60 (2007).